Draw a diagram that shows the price for the vaccine that would arise if the company is unregulated, and label it Pm. What is the efficient price for the vaccine? Show the deadweight loss that arises from the price Pm. On another diagram, show the lowest price that the regulator can enforce that would still induce the pharmaceutical company to develop the vaccine. Label it P*. Show the deadweight loss that arises from this price. How does it compare to the deadweight loss that arises from the price Pm? Suppose you have accurate information about the pharmaceutical company’s fixed cost. How could you use price regulation of the pharmaceutical company, combined with a subsidy to the company, to have the efficient quantity of the vaccine provided at the lowest cost to the government? Concept Introduction: Marginal Social Cost - It refers to the change in the total cost to the society by the production of an additional unit of a commodity. It is the sum of marginal private cost and marginal external cost. Marginal Social benefit - It is the change in the total benefit to the society by the consumption of an extra unit of a commodity. Deadweight loss - It refers to the loss that occurs due the market activities to the society. It is a loss of economic efficiency that takes place during disequilibrium.

Question

Want to see the full answer?

Answer 1

Question

Chapter 17, Problem 12P

To determine

Draw a diagram that shows the price for the vaccine that would arise if the company is unregulated, and label it Pm. What is the efficient price for the vaccine? Show the deadweight loss that arises from the price Pm.

On another diagram, show the lowest price that the regulator can enforce that would still induce the pharmaceutical company to develop the vaccine. Label it P*. Show the deadweight loss that arises from this price. How does it compare to the deadweight loss that arises from the price Pm?

Suppose you have accurate information about the pharmaceutical company’s fixed cost. How could you use price regulation of the pharmaceutical company, combined with a subsidy to the company, to have the efficient quantity of the vaccine provided at the lowest cost to the government?

Concept Introduction:

Marginal Social Cost - It refers to the change in the total cost to the society by the production of an additional unit of a commodity. It is the sum of marginal private cost and marginal external cost.

Marginal Social benefit - It is the change in the total benefit to the society by the consumption of an extra unit of a commodity.

Deadweight loss - It refers to the loss that occurs due the market activities to the society. It is a loss of economic efficiency that takes place during disequilibrium.

Expert Solution & Answer

Want to see the full answer?

Check out a sample textbook solution

See solution

Students have asked these similar questions

Answer question 2 only.

1. A pension fund manager is considering three mutual funds. The first is a stock fund, the second is a long-term government and corporate fund, and the third is a (riskless) T-bill money market fund that yields a rate of 8%. The probability distributions of the risky funds have the following characteristics: Standard Deviation (%) Expected return (%) Stock fund (Rs) 20 30 Bond fund (RB) 12 15 The correlation between the fund returns is .10.

Frederick Jones operates a sole proprietorship business in Trinidad and Tobago. His gross annual revenue in 2023 was $2,000,000. He wants to register for VAT, but he is unsure of what VAT entails, the requirements for registration and what he needs to do to ensure that he is fully compliant with VAT regulations. Make reference to the Vat Act of Trinidad and Tobago and explain to Mr. Jones what VAT entails, the requirements for registration and the requirements to be fully compliant with VAT regulations.